These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 16048495

  • 1. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM, El-Agnaf M.
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Aug; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 3. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 4. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM.
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [Abstract] [Full Text] [Related]

  • 5. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F, Schiavotto C, Castaman G, Vespignani M, Ruggeri M, Dini E.
    Haematologica; 1992 Mar; 77(3):248-52. PubMed ID: 1330848
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A, Mauger D.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [Abstract] [Full Text] [Related]

  • 7. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C, Castaman G, Rodeghiero F.
    Haematologica; 1993 Jan; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [Abstract] [Full Text] [Related]

  • 8. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M.
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [Abstract] [Full Text] [Related]

  • 10. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
    Bussel JB, Kaufmann CP, Ware RE, Woloski BM.
    Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654
    [Abstract] [Full Text] [Related]

  • 11. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ, Acute ITP Study Group.
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P, Busto MJ, Díez JL, Cabrera R, Regidor C, Forés R, Sanjuán I, Briz M, Fernández MN.
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S, Aytaç S, Olcay L, Tunç B, Ozbek N, Aydinok Y.
    Turk J Pediatr; 2010 Jun; 52(2):126-31. PubMed ID: 20560246
    [Abstract] [Full Text] [Related]

  • 14. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G, Diez-Ewald M, Arteaga-Vizcaíno M, Torres E.
    Invest Clin; 1992 Jun; 33(4):165-74. PubMed ID: 1338940
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto.
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD, Francischetti MM.
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [Abstract] [Full Text] [Related]

  • 18. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM, Shalev H, Kapelushnik J.
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
    Cooper N.
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.